Mar. Drugs 2013, 11(9), 3324-3334; doi:10.3390/md11093324
Article

The Effect of Low-Dose Marine n-3 Fatty Acids on Plasma Levels of sCD36 in Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial

1,* email, 1email, 1, 1email and 2email
Received: 13 June 2013; in revised form: 1 August 2013 / Accepted: 8 August 2013 / Published: 30 August 2013
(This article belongs to the Special Issue Marine Fatty Acids)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: CD36 is a scavenger receptor involved in lipid uptake and inflammation. Recently, non-cell-bound CD36 (sCD36) was identified in plasma and suggested to be a marker of lipid accumulation in the vessel wall. Marine n-3 polyunsaturated fatty acids (PUFA) may have cardioprotective effects. This study evaluated the effect of marine n-3 PUFA on sCD36 levels in overweight subjects. Fifty overweight subjects were randomized to 1.1 g of n-3 PUFA or 2 g of olive oil daily for six weeks. Neutrophils were isolated at baseline and after six weeks of treatment while an adipose tissue biopsy was obtained at baseline. The content of n-3 PUFA in adipose tissue and neutrophils was analyzed by gas chromatography, while plasma levels of sCD36 were determined using an enzyme-linked immunosorbent assay (ELISA). After six weeks of supplement plasma sCD36 did not differ between supplements (P = 0.18). There was no significant correlation between plasma sCD36 levels and n-3 PUFA in neutrophils at baseline (r = −0.02, P = 0.88), after six weeks supplement (r = −0.03, P = 0.85) or in adipose tissue (r = 0.14, P = 0.34). This study therefore does not provide evidence for a cardioprotective effect of n-3 PUFA acting through a CD36-dependent mechanism.
Keywords: n-3 PUFA; CD36; adipose tissue; cardiovascular disease; randomised controlled trial
PDF Full-text Download PDF Full-Text [508 KB, uploaded 30 August 2013 11:42 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Venø, S.K.; Nielsen, M.R.S.; Lundbye-Christensen, S.; Schmidt, E.B.; Handberg, A. The Effect of Low-Dose Marine n-3 Fatty Acids on Plasma Levels of sCD36 in Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial. Mar. Drugs 2013, 11, 3324-3334.

AMA Style

Venø SK, Nielsen MRS, Lundbye-Christensen S, Schmidt EB, Handberg A. The Effect of Low-Dose Marine n-3 Fatty Acids on Plasma Levels of sCD36 in Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial. Marine Drugs. 2013; 11(9):3324-3334.

Chicago/Turabian Style

Venø, Stine K.; Nielsen, Michael R.S.; Lundbye-Christensen, Søren; Schmidt, Erik B.; Handberg, Aase. 2013. "The Effect of Low-Dose Marine n-3 Fatty Acids on Plasma Levels of sCD36 in Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial." Mar. Drugs 11, no. 9: 3324-3334.

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert